Sign up to save your podcasts
Or
Share Special Populations and Immune Checkpoint Inhibitors: Are They Safe?
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Special Populations and Immune Checkpoint Inhibitors: Are They Safe?
In this activity, three experts discuss how to incorporate immune checkpoint inhibitor therapy into the management of individuals classified as part of the "special population" of patients not generally included in clinical trials.
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/946383?src=mkm_podcast_addon_946383
View all episodes
By Medscape
4.3
2525 ratings
In this activity, three experts discuss how to incorporate immune checkpoint inhibitor therapy into the management of individuals classified as part of the "special population" of patients not generally included in clinical trials.
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/946383?src=mkm_podcast_addon_946383
More shows like Keeping Current CME
View all
JAMA Editors' Summary
136 Listeners
AFP: American Family Physician Podcast
695 Listeners
JAMA Clinical Reviews
495 Listeners
JACC This Week
170 Listeners
Diabetes Core Update
102 Listeners
This Week in Cardiology
884 Listeners
The Bob Harrington Show
13 Listeners
One-on-One with Eric Topol
17 Listeners
Mayo Clinic Talks
291 Listeners
Frankly Speaking About Family Medicine
259 Listeners
The Curbsiders Internal Medicine Podcast
3,342 Listeners
Core IM | Internal Medicine Podcast
1,158 Listeners
Annals On Call Podcast
195 Listeners
JAMA Medical News
90 Listeners
The Clinical Problem Solvers
513 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
364 Listeners
Freely Filtered, a NephJC Podcast
173 Listeners
Medicine and the Machine
61 Listeners
Keeping Current
8 Listeners
Cardionerds: A Cardiology Podcast
429 Listeners